Search results for "C. Difficile"
Fecal microbiota transplant appears cost-effective for first recurrent C. diff infection
A modeling study found the greatest cost-effectiveness with fidaxomicin for initial nonsevere Clostridioides difficile infection, with vancomycin for initial severe infection, and with fecal microbiota transplant for first and subsequent recurrent infection.
https://acphospitalist.acponline.org/archives/2022/03/23/fecal-microbiota-transplant-appears-cost-effective-for-first-recurrent-c-diff-infection.htm
23 Mar 2022
Computerized clinical decision support may help reduce unnecessary C. diff testing
A two-year cohort study of nine academic and six community hospitals in the U.S. found that testing for Clostridioides difficile decreased when the electronic health record stopped a clinician from proceeding with a test order if the patient had already been tested or had recently received laxatives.
https://acphospitalist.acponline.org/archives/2022/02/09/computerized-clinical-decision-support-may-help-reduce-unnecessary-c-diff-testing.htm
9 Feb 2022
Guidelines suggest fidaxomicin over vancomycin for Clostridioides difficile infection
The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/4.htm
30 Jun 2021
Bezlotoxumab reduced readmissions for C. diff compared to placebo
The industry-funded study found that bezlotoxumab significantly reduced Clostridium difficile–associated readmissions for some patients at high risk of recurrence, including older patients and patients with severe cases.
https://acphospitalist.acponline.org/weekly/archives/2017/08/23/3.htm
23 Aug 2017